Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Hematology Oncology Pharmacy Association
Lobbying Relationship
Bills mentioned
H.R.4385: Cancer Drug Parity Act of 2021
Sponsor: Brian Higgins (D-N.Y.)
H.R.2759: Pharmacy and Medically Underserved Areas Enhancement Act
Sponsor: G. K. Butterfield (D-N.C.)
S.1362: Pharmacy and Medically Underserved Areas Enhancement Act
Sponsor: Charles E. Grassley (R-Iowa)
H.R.5376: Inflation Reduction Act of 2022
Sponsor: John Yarmuth (D-Ky.)
S.3080: Cancer Drug Parity Act of 2021
Sponsor: Tina Smith (D-Minn.)
H.R.7213: Equitable Community Access to Pharmacist Services Act
Sponsor: Ron Kind (D-Wis.)
S.2039: Cancer Drug Parity Act of 2023
Sponsor: Tina Smith (D-Minn.)
S.1491: Pharmacy and Medically Underserved Areas Enhancement Act
Sponsor: Charles E. Grassley (R-Iowa)
H.R.1770: Equitable Community Access to Pharmacist Services Act
Sponsor: Adrian Smith (R-Neb.)
H.R.6301: Cancer Drug Parity Act of 2023
Sponsor: Glenn Grothman (R-Wis.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Jeremy Scott | n/a |
| Zachary Kiser | n/a |
| Stefanie Rinehart | n/a |
| Hermela Mebrahtu | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate